Avrobio Inc (AVRO)
1.21
-0.04
(-3.20%)
USD |
NASDAQ |
Apr 19, 14:17
Avrobio Cash from Investing (TTM): 85.08M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.08M |
| September 30, 2023 | 84.93M |
| June 30, 2023 | 83.64M |
| March 31, 2023 | -0.243M |
| December 31, 2022 | -0.267M |
| September 30, 2022 | -1.117M |
| June 30, 2022 | -1.298M |
| March 31, 2022 | -2.378M |
| December 31, 2021 | -2.461M |
| September 30, 2021 | -1.692M |
| June 30, 2021 | -1.456M |
| March 31, 2021 | -0.715M |
| December 31, 2020 | -1.177M |
| Date | Value |
|---|---|
| September 30, 2020 | -1.862M |
| June 30, 2020 | -1.909M |
| March 31, 2020 | -1.822M |
| December 31, 2019 | -1.585M |
| September 30, 2019 | -1.053M |
| June 30, 2019 | -2.173M |
| March 31, 2019 | -1.909M |
| December 31, 2018 | -1.832M |
| September 30, 2018 | -1.679M |
| June 30, 2018 | -0.721M |
| March 31, 2018 | -0.591M |
| December 31, 2017 | -0.383M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.461M
Minimum
Dec 2021
85.08M
Maximum
Dec 2023
12.13M
Average
-1.298M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Axonics Inc | -116.90M |
| Catalent Inc | -410.00M |
| AIM ImmunoTech Inc | -0.832M |
| Protalix BioTherapeutics Inc | -16.71M |
| Armata Pharmaceuticals Inc | -8.134M |